Facebook-f Instagram Twitter Linkedin-in Youtube

Why Nextleaf Solutions Is Betting That Patents Are The Future Of Cannabis

  • July 15, 2020

Home / News / Why Nextleaf Solutions Is Betting That Patents Are The Future Of Cannabis

As the economic crisis brought upon by COVID-19 lays waist to industries like retail, tourism, and restaurants, the cannabis industry is facing a different kind of crisis. 

Despite record legal cannabis sales in major markets (which can be attributed to the pandemic) cannabis producers have had to grapple with an uncomfortable truth: there is too much weed. This fact remains true for both Canadian and U.S. companies, even though cannabis remains federally illegal in the latter. 

Predictably, the oversupply of cannabis and hemp has created downward pressure on prices, a problem for companies in the business of selling cannabis-based products. 

“We’re seeing lower grade flower commoditized, the price of distillate commoditized, and it puts even more strain on processors that are not the most efficient,” said Paul Pedersen, co-founder and CEO of Nextleaf Solutions OILFF 11.92%. “Because as the price of the commodity you’re selling comes down, you’ve got to be able to lean on price and efficiency.”

This is why, as Pedersen describes it, the future of the cannabis industry is not a question of who can grow the most, sell the most, or even make the best product. It’s about who can develop, and license, the most efficient methods of processing cannabis from flower to oil.

Follow The Smart Money

In October 2018, Canopy Growth Corp CGC 4.08% paid $330 million to acquire Ebbu, a Colorado-based research company. In the accompanying release, Canopy touted Ebbu’s intellectual property as the reason for the deal, specifically its IP around incorporating cannabinoids into beverages. 

Ultimately, Canopy hasn’t been able to turn that IP into issued patents. But Pedersen said the fact that the largest cannabis company by market cap would spend that amount of money on acquiring intellectual property reflects the opportunity at hand. 

“That transaction really represents what the smart money realizes. That where the opportunity here isn’t growing plants indoors, it’s companies that can develop intellectual property and patents that are defensible commercially and have value in 20 years.”

Pedersen pointed to the technology, biotech, and life sciences industries, where intellectual property can be a big driver of M&A activity. The fact that cannabis is a controlled substance makes IP as important for cannabis companies as it does for pharmaceuticals. 

“It’s no different in many ways than any pharmaceutical. It can be grown at scale in a plant, but because it’s been illicit and it’s something that people can smoke recreationally, people don’t think about IP.”

According to Pedersen, seven of the top 10 companies that were awarded the most cannabis-based patents in Canada last year are big pharma companies, including companies like Pfizer Inc PFE -0.87% and Merck & Co. MRK -0.85%. 

“That says a lot right there about where the smart money is focused,” he said. “Merck isn’t trying to build greenhouses and grow plants indoors. They’re focused on securing 20-year patents based on extraction formulations.”


New Traders Swear By Benzinga Options

We sift through this volatile market for consistent trades so you don’t have to. Get Benzinga Options: Starter Edition to follow Benzinga’s high-conviction options trades. 

Click here to get my trades!


Going All In

Nextleaf, a Vancouver, British Columbia-based company, has built its entire businesses on establishing a portfolio of intellectual property. Since its founding in late 2016, the company has been awarded more than 60 cannabis-related patents (12 of which are in the U.S.), second only to Canopy Growth.

Those patents are based around the extraction, refining, and distillation of lower-grade cannabis into THC and CBD oils. For example, the company currently has a patent pending involving a nano emulsification technique used in the dairy industry that could be also be used for cannabis beverages. 

“We’re big believers in that there’s more of a commercial opportunity not in selling cannabis, but actually selling the means of production,” Pedersen said. “From day one of this company we’ve said ‘We’ll never grow a plant.’ We want to focus on what we feel is the highest value part of the supply chain, which is taking the lower grade cannabis that can’t be sold, grinding it up, extracting it, pulling out the cannabinoids and other chemical elements, being able to separate, isolate, and reformulate in novel ways in standardized products.”

What’s Going To Happen When The U.S. Jumps In

For the time being, the entire industry is hamstrung by the legal status of cannabis in the U.S. 

As long as the substance remains illegal at the federal level, companies will be limited in how they can enter the industry. Pedersen pointed to a pair of high-profile investments—

Constellation Brands, Inc STZ -1.51%-38% stake in Canopy Growth, and Altria Group’s MO 0.44% 45% stake in Cronos Group Inc CRON 9.63%—as evidence of the industry’s present limitations. 

“The reality is those deals happened not because Constellation and Altria wanted to dominate the Canadian cannabis industry, they did it because they can’t invest in U.S.- based cannabis companies,” said Pedersen. 

This puts Canadian companies at a unique advantage over American companies right now, though that would change if, as many industry participants predict, cannabis ever becomes federally legalized. Until that happens, the land grab for cannabis IP is, as Pedersen put it, “a once in a lifetime event” for Canadian companies like Nextleaf.

“Those deals are a good example of when cannabis does get legalized you’re going to see a lot more research and development, you’re going to see more universities get into it, and you’re going to see the technology around cultivation processing and formulation really evolve from where we are now.”

UPDATE: Two of the largest cannabis companies are now embroiled in a patent lawsuit. In December, Canopy Growth sued GW Pharmaceuticals GWPH -0.74% in U.S. federal court alleging the British pharma company used its intellectual property related to a CBD extraction method.

 

Read the full article from Benzinga here: 

Most Recent Videos

Nextleaf announces All Glacial Gold Products are now available Nationally through Mendo Medical

  • January 17, 2022
Watch Full Video
Video

Nextleaf Solutions seeing strong sale start to re-launch of legacy brand Glacial Gold

  • October 5, 2021
Watch Full Video
Video

Nextleaf Solutions starts distribution in Saskatchewan as they restock in British Columbia

  • September 22, 2021
Watch Full Video
Video

Nextleaf Solutions awarded 16th US patent for synthesizing CBG-O-Acetate

  • September 15, 2021
Watch Full Video
Video

Nextleaf announces All Glacial Gold Products are now available Nationally through Mendo Medical

  • January 17, 2022

Nextleaf Solutions seeing strong sale start to re-launch of legacy brand Glacial Gold

  • October 5, 2021

Nextleaf Solutions starts distribution in Saskatchewan as they restock in British Columbia

  • September 22, 2021

Nextleaf Solutions awarded 16th US patent for synthesizing CBG-O-Acetate

  • September 15, 2021

Nextleaf Solutions delivers first shipment of Glacial Gold to BC Liquor Distribution Branch

  • September 9, 2021

Nextleaf Solutions updates on growth of its CBD oil business as it launches Glacial Gold

  • August 6, 2021

Interested in investing in Nextleaf?

Exclusive access to monthly insights from Canada’s most innovative cannabis processor. Join over 7000+ subscribers world-wide!

sign up for updates

The Latest from OILS

Loading...
patent psychedelic thc-o-acetate nextleaf

Nextleaf Partners with NOYA Cannabis for the Canadian Launch of Cookies “C” Branded Vapes (CSE: OILS) (OTCQB: OILFF)

Nextleaf is supplying Atlantic with semi-finished goods to power several unique products under their Crooked Dory brand.
Read Now
Loading...
Cannabis, Chemistry, & Agrology: Why Professional Designations Matter Within The Cannabis Industry

Cannabis, Chemistry, & Agrology: Why Professional Designations Matter Within The Cannabis Industry

Professional designations and accreditation can be a meaningful and valuable way to differentiate the strength of the team behind a brand or company, and their ability to deliver operational excellence and quality.
Read Now
Loading...
What Does Distillate Cost in Canada?

What Does Distillate Cost In Canada?

There is a combination of fixed and fluctuating factors that affect pricing. This is relevant context for cultivators looking to maximize the value of their harvest, and manufacturers looking to create competitive pricing in their portfolio of cannabis derivative products.
Read Now

Exclusive access to monthly insights from the world’s most innovative cannabis
processor. Join over 7000+ subscribers world-wide.

info@nextleafsolutions.com

  • Privacy
  • Cookie Policy
Menu
  • Privacy
  • Cookie Policy
Linkedin-in Facebook-f Instagram Twitter Youtube
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. Read More
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
  • Our Story
    • Team
  • Brands
  • Extraction Tech
    • Rapid Emulsion Tech
  • Services
    • Toll Processing
    • Bulk Sales &
      Purchasing
    • Research &
      Product Development
  • Investor
    • Press Releases
    • Financial Filings
    • Investor Deck
  • Media
    • Insights
    • News
  • Contact
Menu
  • Our Story
    • Team
  • Brands
  • Extraction Tech
    • Rapid Emulsion Tech
  • Services
    • Toll Processing
    • Bulk Sales &
      Purchasing
    • Research &
      Product Development
  • Investor
    • Press Releases
    • Financial Filings
    • Investor Deck
  • Media
    • Insights
    • News
  • Contact
Menu
  • Our Story
    • Team
  • Brands
  • Extraction Tech
    • Rapid Emulsion Tech
  • Services
    • Toll Processing
    • Bulk Sales &
      Purchasing
    • Research &
      Product Development
  • Investor
    • Press Releases
    • Financial Filings
    • Investor Deck
  • Media
    • Insights
    • News
  • Contact
Facebook-f Instagram Twitter Linkedin-in Youtube

SIGN-UP NOW!

Exclusive access to monthly insights from the world’s most innovative cannabis processor. Join over 7000+ subscribers world-wide.
Unsubscribe at any time. Your email will not be shared or distributed. View our privacy policy.

Confirm Your Age

By selecting yes, I certify that I am of legal age in my jurisdiction to consume cannabis.

YES
YES
NO
Remember my answer

INVEST IN THE FUTURE OF CANNABIS

Please enter your email below to receive the Nextleaf Solutions Investor Kit.
Unsubscribe at any time. Your email will not be shared or distributed. View our privacy policy.